Psychedelic Science Funders Collaborative
Non-profit Organizations • 
San Francisco, California, United States • 11-20 Employees
Company overview
| Headquarters | San Francisco, California, United States |
| Website | |
| NAICS | 813 |
| Founded | 2017 |
| Employees | 11-20 |
| Socials |
Key Contacts at Psychedelic Science Funders Collaborative
Genevieve Wolff Jurvetson
Chair, Founders Circle, Board Member
Ben Collins
Director Of Programs And Partnerships
Nora Benavidez
Director Of Operations
Psychedelic Science Funders Collaborative Email Formats
Psychedelic Science Funders Collaborative uses 2 email formats. The most common is {first initial} (e.g., j@psfc.co), used 87.5% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@psfc.co | 87.5% |
{first name} | john@psfc.co | 12.5% |
About Psychedelic Science Funders Collaborative
Psychedelic Science Funders Collaborative (PSFC), a 501(c)(3) nonprofit, is a funding collaborative created to support the exceptional scientists and organizations working on psychedelic clinical trials and to ensure psychedelic treatments reach all who can benefit. Emerging research indicates that psychedelics have the potential to be a breakthrough in treating PTSD, depression, addiction, and other conditions. PSFC was born in 2017 out of a realization that psychedelic medicine has the potential to make an enormous impact and has an achievable path to regulatory approval, but has been systemically underfunded. Since PSFC’s founding, we have grown into a community of many of the leading funders of psychedelic medicine supporting organizations at the cutting edge of psychedelic research with funding and expert support. PSFC has funded several organizations at the forefront of the psychedelic field, and in 2020, we completed a $30 million fundraising campaign in partnership with the Multidisciplinary Association for Psychedelic Studies (MAPS) to support the completion of phase 3 clinical trials of MDMA-assisted psychotherapy. PSFC’s current areas of focus include supporting broad and equitable access to high-quality MDMA-assisted psychotherapy post-FDA approval, and supporting the implementation of Oregon’s Measure 109, which authorizes psilocybin therapy in the state, to ensure the program also provides broad and equitable access to high-quality care.
Psychedelic Science Funders Collaborative revenue & valuation
| Annual revenue | $1,026,660 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Non-profit Organizations industry and current estimated revenues | $3,300,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Psychedelic Science Funders Collaborative has 5 employees across 5 departments.
Departments
Number of employees
Funding Data
Psychedelic Science Funders Collaborative has never raised funding before.
Psychedelic Science Funders Collaborative Tech Stack
Discover the technologies and tools that power Psychedelic Science Funders Collaborative's digital infrastructure, from frameworks to analytics platforms.
Font scripts
JavaScript libraries
JavaScript libraries
Security
Ecommerce
JavaScript frameworks
Security
Miscellaneous
JavaScript libraries
JavaScript libraries
CMS
United Kingdom
Frequently asked questions
4.8
40,000 users
